De-extinction Startup Colossal Biosciences Eyes $30 Billion Valuation as AI Accelerates Mammoth and Species Revival

Colossal Biosciences, a San Francisco-based synthetic biology company co-founded by serial entrepreneur Ben Lamm and Harvard geneticist George Church, has become a billion-dollar powerhouse in the nascent de-extinction field, commanding a current valuation of $10.2 billion and seeking up to $30 billion in an ongoing funding round. The startup applies artificial intelligence, CRISPR gene editing, and computational biology to resurrect extinct species, fundamentally shifting what scientists believe is possible in conservation and ecosystem restoration.